Identification of potential inhibitors against pathogenic missense mutations of PMM2 using a structure-based virtual screening approach

2020 ◽  
Vol 39 (1) ◽  
pp. 171-187 ◽  
Author(s):  
D. Thirumal Kumar ◽  
Nikita Jain ◽  
S. Udhaya Kumar ◽  
C. George Priya Doss ◽  
Hatem Zayed
Keyword(s):  
Virtual Screening ◽  
Missense Mutations ◽  
Screening Approach ◽  
Potential Inhibitors ◽  
Virtual Screening Approach

scholarly journals Simeprevir and Eltrombopag as Potential Inhibitors of SARS-CoV2 Proteases: A Molecular Docking and Virtual Screening Approach to Combat COVID-19

2020 ◽  
Author(s):  
Ananta Swargiary ◽  
AKALESH Verma ◽  
Manita Daimari ◽  
Mritunjoy Kumar Roy
Keyword(s):  
Molecular Docking ◽  
Virtual Screening ◽  
Binding Affinities ◽  
Screening Approach ◽  
Approved Drugs ◽  
Potential Inhibitors ◽  
Fda Approved Drugs ◽  
Virtual Screening Approach

The present study investigates the binding affinities of 61 FDA approved drugs against two key proteases of SARS-COV2, 3-chymotrypsin-like protease and papain-like protease. We also investigates the ADMET properties of the top 10 besting binding drugs to understand the drug likeness property.

scholarly journals Assessing Potential Inhibitors for SARS-CoV-2 Main Protease from Available Drugs using Free Energy Perturbation Simulations

2020 ◽  
Author(s):  
Son Tung Ngo ◽  
Hung Minh Nguyen ◽  
Le Thi Thuy Huong ◽  
Pham Minh Quan ◽  
Vi Khanh Truong ◽  
...  
Keyword(s):  
Free Energy ◽  
Virtual Screening ◽  
Binding Affinity ◽  
Free Energy Perturbation ◽  
Screening Approach ◽  
Main Protease ◽  
Energy Perturbation ◽  
Potential Inhibitors ◽  
Virtual Screening Approach

A virtual screening approach using docking and free energy pertubation was successfully validated with previously characterized inhibitors of SARS-CoV-2 main protease (Mpro). This approach and then used to estimate the binding affinity to Mpro of more than 6300 compounds in the ZINC15 database. Delamanid, an anti-tuberculosis agent, has a predicted nanomolar binding affinity for SARS-CoV-2 Mpro and is thus a promissing drug candiate for COVID-19. In addition, several compounds including three antibiotics exhibits femtomolar affinity for SARS-CoV-2 Mpro. The residues around positions 24, 45, 143, 165, and 190 were found to be involved in the binding of the strongest inhibitors.

Surveying FDA-approved drugs as new potential inhibitors of N-cadherin protein: a virtual screening approach

2020 ◽  
Vol 31 (6) ◽  
pp. 2355-2369
Author(s):  
Sahar Khajeh ◽  
Mahboobeh Eslami ◽  
Navid Nezafat ◽  
Zohreh Mostafavi-Pour ◽  
Manica Negahdaripour ◽  
...  
Keyword(s):  
Virtual Screening ◽  
Protein A ◽  
Screening Approach ◽  
Approved Drugs ◽  
Potential Inhibitors ◽  
Fda Approved Drugs ◽  
Virtual Screening Approach

scholarly journals Simeprevir and Eltrombopag as Potential Inhibitors of SARS-CoV2 Proteases: A Molecular Docking and Virtual Screening Approach to Combat COVID-19

2020 ◽  
Author(s):  
Ananta Swargiary ◽  
AKALESH Verma ◽  
Manita Daimari ◽  
Mritunjoy Kumar Roy
Keyword(s):  
Molecular Docking ◽  
Virtual Screening ◽  
Binding Affinities ◽  
Screening Approach ◽  
Approved Drugs ◽  
Potential Inhibitors ◽  
Fda Approved Drugs ◽  
Virtual Screening Approach

The present study investigates the binding affinities of 61 FDA approved drugs against two key proteases of SARS-COV2, 3-chymotrypsin-like protease and papain-like protease. We also investigates the ADMET properties of the top 10 besting binding drugs to understand the drug likeness property.

Structure-based virtual screening and ADME/T-based profiling for low molecular weight chemical starting points as p21-activated kinase 4 inhibitors

RSC Advances ◽  
2015 ◽  
Vol 5 (30) ◽  
pp. 23202-23209 ◽  
Author(s):  
Ruijuan Li ◽  
Xiaolin Su ◽  
Zheng Chen ◽  
Wanxu Huang ◽  
Yali Wang ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Virtual Screening ◽  
Chemical Modification ◽  
Low Molecular Weight ◽  
Screening Approach ◽  
P21 Activated Kinase ◽  
Virtual Screening Approach

Novel PAK4 inhibitors were discovered using structure-based virtual screening approach for further chemical modification.

scholarly journals Identification of Previously Unrecognized Antiestrogenic Chemicals Using a Novel Virtual Screening Approach

2006 ◽  
Vol 19 (12) ◽  
pp. 1595-1601 ◽  
Author(s):  
Ching Y. Wang ◽  
Ni Ai ◽  
Sonia Arora ◽  
Karthigeyan Nagarajan ◽  
Randy Zauhar ◽  
...  
Keyword(s):  
Virtual Screening ◽  
Screening Approach ◽  
Virtual Screening Approach

Identification of Novel Antitubulin Agents by Using a Virtual Screening Approach Based on a 7-Point Pharmacophore Model of the Tubulin Colchi-Site

2011 ◽  
Vol 78 (6) ◽  
pp. 913-922 ◽  
Author(s):  
Alberto Massarotti ◽  
Sewan Theeramunkong ◽  
Ornella Mesenzani ◽  
Antonio Caldarelli ◽  
Armando A. Genazzani ◽  
...  
Keyword(s):  
Virtual Screening ◽  
Pharmacophore Model ◽  
Screening Approach ◽  
Virtual Screening Approach

scholarly journals GPCR Structure-Based Virtual Screening Approach for CB2 Antagonist Search.

ChemInform ◽  
2007 ◽  
Vol 38 (42) ◽  
Author(s):  
Jian-Zhong Chen ◽  
Junmei Wang ◽  
Xiang-Qun Xie
Keyword(s):  
Virtual Screening ◽  
Screening Approach ◽  
Gpcr Structure ◽  
Virtual Screening Approach
Sign in / Sign up

Export Citation Format

Share Document